Cash flow VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
0.5596 ^USD	+0.48%		-1.15%	-3.53%

Dec. 18	RTW Biotech Opportunities announces new investment in Yarrow Bioscience	RE
Dec. 17	VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call

2a8c168.RgyZQaCncXTQvTOhQxV-nGH2YcFBp8LN97xAn2OR37U.IEvALO6eFDLm8X3kJyRH2hmcMKkslPKI2sUB6C6iitoDetQk7MFDTKr1Bw

Published financial data: VYNE THERAPEUTICS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	20.99M	14.76M	477K	424K	501K
Total Revenues	20.99M	14.76M	477K	424K	501K
Cost of Goods Sold, Total	1.39M	3.35M	-	-	-
Gross Profit	19.6M	11.41M	477K	424K	501K
Selling General & Admin Expenses, Total	77.14M	54.48M	16.39M	13.38M	13.19M
R&D Expenses	39.73M	24.96M	18.38M	16.31M	30.95M
Other Operating Expenses, Total	117M	79.44M	34.77M	29.68M	44.14M
Operating Income	-97.28M	-68.03M	-34.3M	-29.26M	-43.64M
Interest Expense, Total	-4.39M	-5.61M	-	-	-
Interest And Investment Income	-	-	-	1.39M	3.83M
Net Interest Expenses	-4.39M	-5.61M	-	1.39M	3.83M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	968K	-135K	363K	-	-
EBT, Excl. Unusual Items	-101M	-73.78M	-33.93M	-27.87M	-39.8M
Merger & Related Restructuring Charges	-16.2M	-	-	-	-
Impairment of Goodwill	-4.54M	-	-	-	-
Gain (Loss) On Sale Of Investments	142K	-	-	-	-
In Process R&D Expenses	-49.8M	-	-	-	-
Other Unusual Items	-84.73M	-	-	-	-
EBT, Incl. Unusual Items	-256M	-73.78M	-33.93M	-27.87M	-39.8M
Income Tax Expense	-258K	-448K	13K	-	4K
Earnings From Continuing Operations	-256M	-73.33M	-33.94M	-27.87M	-39.81M
Earnings Of Discontinued Operations	-	-	10.74M	-580K	-27K
Net Income to Company	-256M	-73.33M	-23.21M	-28.45M	-39.83M
Net Income - (IS)	-256M	-73.33M	-23.21M	-28.45M	-39.83M
Preferred Dividend and Other Adjustments	-	-	-	149K	-
Net Income to Common Incl Extra Items	-256M	-73.33M	-23.21M	-28.6M	-39.83M
Net Income to Common Excl. Extra Items	-256M	-73.33M	-33.94M	-28.02M	-39.81M
Per Share Items
Net EPS - Basic	-141.9	-25.64	-7.28	-2.78	-0.94
Basic EPS - Continuing Operations	-141.9	-25.64	-10.65	-2.73	-0.93
Basic Weighted Average Shares Outstanding	1.8M	2.86M	3.19M	10.27M	42.59M
Net EPS - Diluted	-141.9	-25.64	-7.28	-2.78	-0.94
Diluted EPS - Continuing Operations	-141.9	-25.64	-10.65	-2.73	-0.93
Diluted Weighted Average Shares Outstanding	1.8M	2.86M	3.19M	10.27M	42.59M
Normalized Basic EPS	-34.94	-16.13	-6.66	-1.7	-0.58
Normalized Diluted EPS	-34.94	-16.13	-6.66	-1.7	-0.58
Supplemental Items
EBITDA	-96.93M	-67.92M	-34.22M	-29.19M	-43.63M
EBITA	-97.28M	-68.03M	-34.3M	-29.26M	-43.64M
EBIT	-97.28M	-68.03M	-34.3M	-29.26M	-43.64M
EBITDAR	-95.58M	-67.13M	-33.93M	-29.08M	-43.5M
Total Revenues (As Reported)	20.99M	14.76M	477K	424K	501K
Effective Tax Rate - (Ratio)	0.1	0.61	-0.04	-	-0.01
Current Domestic Taxes	-253K	-448K	13K	-121K	4K
Current Foreign Taxes	-	-	-	121K	-
Total Current Taxes	-253K	-448K	13K	0	4K
Normalized Net Income	-62.94M	-46.11M	-21.21M	-17.42M	-24.88M
Interest on Long-Term Debt	4.4M	5.6M	-	-	-
Non-Cash Pension Expense	8.5M	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	43.53M	24.96M	18.38M	16.31M	30.95M
Net Rental Expense, Total	1.35M	791K	297K	102K	136K
Imputed Operating Lease Interest Expense	1.37M	2.02M	-	-	-
Imputed Operating Lease Depreciation	-19.23K	-1.23M	-	-	-
Stock-Based Comp., COGS (Total)	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	4.75M	1.71M	1.23M	534K	548K
Stock-Based Comp., SG&A Exp. (Total)	13.35M	6.37M	3.42M	2.77M	2.76M
Total Stock-Based Compensation	18.1M	8.08M	4.65M	3.3M	3.3M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	57.56M	42.25M	30.91M	30.62M	19.93M
Short Term Investments	1.03M	-	-	62.63M	41.59M
Total Cash And Short Term Investments	58.59M	42.25M	30.91M	93.25M	61.52M
Accounts Receivable, Total	15.82M	7.58M	173K	-	-
Other Receivables	-	-	5M	-	-
Total Receivables	15.82M	7.58M	5.17M	-	-
Inventory	7.4M	7.29M	-	-	-
Prepaid Expenses	4.59M	5.12M	2.13M	2.66M	2.92M
Restricted Cash	855K	605K	67K	54K	-
Other Current Assets, Total	-	338K	-	-	-
Total Current Assets	87.26M	63.19M	38.28M	95.96M	64.44M
Gross Property Plant And Equipment	2.58M	905K	-	-	210K
Accumulated Depreciation	-443K	-551K	-	-	-4K
Net Property Plant And Equipment	2.14M	354K	-	207K	206K
Long-term Investments	-	-	-	-	-
Other Long-Term Assets, Total	4.34M	3.51M	2.48M	1.52M	2.26M
Total Assets	93.74M	67.05M	40.76M	97.68M	66.9M
Liabilities
Accounts Payable, Total	4.78M	6.51M	2.39M	1.66M	2.71M
Accrued Expenses, Total	10.01M	6.05M	4.26M	3.51M	8.59M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	757K	349K	-	115K	99K
Unearned Revenue Current, Total	5.8M	5.5M	-	-	-
Other Current Liabilities	104K	-	2.7M	2.25M	3.42M
Total Current Liabilities	21.45M	18.41M	9.34M	7.54M	14.82M
Long-Term Debt	33.17M	-	-	-	-
Long-Term Leases	853K	-	-	99K	-
Pension & Other Post Retirement Benefits	312K	-	-	-	-
Other Non Current Liabilities	457K	-	-	1.31M	-
Total Liabilities	56.25M	18.41M	9.34M	8.95M	14.82M
Preferred Stock Convertible	-	-	211K	-	-
Total Preferred Equity	-	-	211K	-	-
Common Stock, Total	4K	5K	-	1K	1K
Additional Paid In Capital	604M	688M	694M	780M	783M
Retained Earnings	-566M	-640M	-663M	-691M	-731M
Comprehensive Income and Other	-	-	-	26K	20K
Total Common Equity	37.49M	48.64M	31.2M	88.74M	52.09M
Total Equity	37.49M	48.64M	31.41M	88.74M	52.09M
Total Liabilities And Equity	93.74M	67.05M	40.76M	97.68M	66.9M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.85M	3.12M	3.26M	14.1M	15.21M
ECS Total Common Shares Outstanding	2.4M	2.98M	3.23M	14.1M	14.83M
Book Value / Share	15.62	16.34	9.66	6.29	3.51
Tangible Book Value	37.49M	48.64M	31.2M	88.74M	52.09M
Tangible Book Value Per Share	15.62	16.34	9.66	6.29	3.51
Total Debt	34.78M	349K	0	214K	99K
Net Debt	-23.81M	-41.9M	-30.91M	-93.04M	-61.42M
Debt Equivalent of Unfunded Proj. Benefit Obligation	312K	206K	206K	-	-
Debt Equivalent Oper. Leases	10.81M	6.33M	2.38M	816K	1.09M
Account Code - Inventory Valuation	5	5	5	3	3
Inventories - Raw Materials, Total	4.04M	3.3M	-	-	-
Inventories - Work In Process, Total	662K	33K	-	-	-
Inventories - Finished Goods, Total	2.7M	3.96M	-	-	-
Machinery, Total	939K	846K	-	-	117K
Full Time Employees	106	28	12	10	13
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-256M	-73.33M	-23.21M	-28.45M	-39.83M
Depreciation & Amortization - CF	341K	109K	72K	-	4K
Depreciation & Amortization, Total	341K	109K	72K	-	4K
(Gain) Loss From Sale Of Asset	2.1M	93K	282K	-	-
(Gain) Loss on Sale of Investments - (CF)	-142K	-	-	-255K	-2.44M
Asset Writedown & Restructuring Costs	54.34M	-	-	-	-
Stock-Based Compensation (CF)	18.1M	8.08M	4.3M	3.3M	3.3M
Net Cash From Discontinued Operations	-	-	-12.92M	-	-
Other Operating Activities, Total	84.07M	3.9M	-	1K	-1K
Change In Accounts Receivable	-17.14M	7.71M	11.21M	405K	-899K
Change In Inventories	-6.05M	113K	97K	-	-
Change In Accounts Payable	-12.98M	-2.68M	-8.68M	-559K	6.01M
Change in Other Net Operating Assets	-4.17M	-371K	-349K	214K	-114K
Cash from Operations	-137M	-56.37M	-29.2M	-25.34M	-33.97M
Capital Expenditure	-113K	-	-	-	-117K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	38.64M	-	-	-	-
Investment in Marketable and Equity Securities, Total	50.58M	1.03M	-	-62.35M	23.48M
Other Investing Activities, Total	-	-	15.67M	5M	-
Cash from Investing	89.11M	1.03M	15.67M	-57.35M	23.36M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-36.43M	-	-	-
Total Debt Repaid	-	-36.43M	-	-	-
Issuance of Common Stock	61.95M	76.5M	1.47M	82.82M	-
Repurchase of Common Stock	-141K	-294K	-	-67K	-141K
Issuance of Preferred Stock	-	-	211K	-	-
Repurchase of Preferred Stock	-	-	-	-360K	-
Other Financing Activities, Total	-	-	-28K	-	-
Cash from Financing	61.81M	39.78M	1.65M	82.39M	-141K
Foreign Exchange Rate Adjustments	1K	-	-	-	-
Net Change in Cash	13.83M	-15.56M	-11.88M	-301K	-10.75M
Supplemental Items
Cash Interest Paid	3.94M	2.38M	-	-	-
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-77.11M	-33.05M	-11.86M	-12.25M	-17M
Unlevered Free Cash Flow	-74.37M	-29.54M	-11.86M	-12.25M	-17M
Change In Net Working Capital	31.9M	-4.79M	-4.85M	-2.74M	-7.09M
Net Debt Issued / Repaid	-	-36.43M	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-69.52	-52.89	-39.77	-26.42	-33.14
Return on Total Capital	-97.81	-70.13	-53.32	-30.39	-38.65
Return On Equity %	-928.19	-170.28	-84.81	-46.4	-56.54
Return on Common Equity	-928.19	-170.28	-85.03	-46.73	-56.54
Margin Analysis
Gross Profit Margin %	93.37	77.31	100	100	100
SG&A Margin	367.47	369.24	3.44K	3.15K	2.63K
EBITDA Margin %	-461.74	-460.34	-7.17K	-6.88K	-8.71K
EBITA Margin %	-463.37	-461.08	-7.19K	-6.9K	-8.71K
EBIT Margin %	-463.37	-461.08	-7.19K	-6.9K	-8.71K
Income From Continuing Operations Margin %	-1.22K	-496.98	-7.12K	-6.57K	-7.95K
Net Income Margin %	-1.22K	-496.98	-4.87K	-6.71K	-7.95K
Net Avail. For Common Margin %	-1.22K	-496.98	-7.12K	-6.61K	-7.95K
Normalized Net Income Margin	-299.79	-312.51	-4.45K	-4.11K	-4.97K
Levered Free Cash Flow Margin	-367.33	-224	-2.49K	-2.89K	-3.39K
Unlevered Free Cash Flow Margin	-354.26	-200.24	-2.49K	-2.89K	-3.39K
Asset Turnover
Asset Turnover	0.24	0.18	0.01	0.01	0.01
Fixed Assets Turnover	6.25	11.84	-	-	2.43
Receivables Turnover (Average Receivables)	2.63	1.26	0.12	-	-
Inventory Turnover (Average Inventory)	0.32	0.46	-	-	-
Short Term Liquidity
Current Ratio	4.07	3.43	4.1	12.73	4.35
Quick Ratio	3.47	2.71	3.86	12.37	4.15
Operating Cash Flow to Current Liabilities	-6.39	-3.06	-3.12	-3.36	-2.29
Days Sales Outstanding (Average Receivables)	139.07	289.45	2.97K	-	-
Days Outstanding Inventory (Average Inventory)	1.15K	801.03	-	-	-
Average Days Payable Outstanding	593.57	636.92	-	-	-
Cash Conversion Cycle (Average Days)	697.14	453.56	-	-	-
Long Term Solvency
Total Debt/Equity	92.77	0.72	-	0.24	0.19
Total Debt / Total Capital	48.13	0.71	-	0.24	0.19
LT Debt/Equity	90.76	-	-	0.11	-
Long-Term Debt / Total Capital	47.08	-	-	0.11	-
Total Liabilities / Total Assets	60	27.46	22.93	9.16	22.15
EBIT / Interest Expense	-22.16	-12.13	-	-	-
EBITDA / Interest Expense	-21.77	-11.97	-	-	-
(EBITDA - Capex) / Interest Expense	-21.8	-11.97	-	-	-
Total Debt / EBITDA	-0.36	-0.01	-	-0.01	-0
Net Debt / EBITDA	0.25	0.62	0.9	3.2	1.41
Total Debt / (EBITDA - Capex)	-0.36	-0.01	-	-0.01	-0
Net Debt / (EBITDA - Capex)	0.25	0.62	0.9	3.2	1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.64K	-29.71	-48.76	-11.11	18.16
Gross Profit, 1 Yr. Growth %	4.32K	-41.8	-48.76	-11.11	18.16
EBITDA, 1 Yr. Growth %	1.48	-39.96	-11.8	-14.72	49.5
EBITA, 1 Yr. Growth %	1.46	-40.05	-11.86	-14.69	49.15
EBIT, 1 Yr. Growth %	1.46	-40.05	-11.86	-14.69	49.15
Earnings From Cont. Operations, 1 Yr. Growth %	168.52	-71.31	-23.22	-17.89	42.82
Net Income, 1 Yr. Growth %	168.52	-71.31	-68.35	22.58	40
Normalized Net Income, 1 Yr. Growth %	5.21	-36.89	-24.01	-17.86	42.81
Diluted EPS Before Extra, 1 Yr. Growth %	-29.72	-81.93	-31.1	-74.4	-65.73
Accounts Receivable, 1 Yr. Growth %	11.62K	-52.06	-97.72	-	-
Inventory, 1 Yr. Growth %	446.02	-1.53	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-53.31	-83.44	-	-	-0.48
Total Assets, 1 Yr. Growth %	15.5	-28.48	-39.21	139.67	-31.51
Tangible Book Value, 1 Yr. Growth %	113.33	29.72	-35.85	184.39	-41.3
Common Equity, 1 Yr. Growth %	113.33	29.72	-35.85	184.39	-41.3
Cash From Operations, 1 Yr. Growth %	86.78	-58.88	-48.2	-13.22	34.06
Capital Expenditures, 1 Yr. Growth %	-89.32	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	91.5	-61.98	-25.75	3.25	38.79
Unlevered Free Cash Flow, 1 Yr. Growth %	87.37	-64.9	-4.87	3.25	38.79
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	141.65	477.12	-84.93	-32.51	2.48
Gross Profit, 2 Yr. CAGR %	133.5	407.44	-84.4	-32.51	2.48
EBITDA, 2 Yr. CAGR %	14.01	-15.68	-45	-13.27	12.91
EBITA, 2 Yr. CAGR %	13.97	-15.76	-45.02	-13.29	12.8
EBIT, 2 Yr. CAGR %	13.97	-15.76	-45.02	-13.29	12.8
Earnings From Cont. Operations, 2 Yr. CAGR %	85.63	-12.23	-63.56	-20.6	8.29
Net Income, 2 Yr. CAGR %	85.63	-12.23	-69.86	-37.71	31.01
Normalized Net Income, 2 Yr. CAGR %	16.85	-12.2	-46.12	-21	8.31
Diluted EPS Before Extra, 2 Yr. CAGR %	-17.09	-64.36	-72.6	-58	-70.38
Accounts Receivable, 2 Yr. CAGR %	285.22	649.47	-89.54	-	-
Inventory, 2 Yr. CAGR %	-	131.88	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.19	-72.2	-	-23.53	-
Total Assets, 2 Yr. CAGR %	-4.94	-9.11	-34.06	20.71	28.12
Tangible Book Value, 2 Yr. CAGR %	-36.22	66.35	-8.77	35.07	29.2
Common Equity, 2 Yr. CAGR %	-36.22	66.35	-8.77	35.07	29.2
Cash From Operations, 2 Yr. CAGR %	41.29	-12.36	-53.85	-32.95	7.86
Capital Expenditures, 2 Yr. CAGR %	-55.36	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	35.87	-9.4	-63.06	-12.44	19.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.43	-13.72	-62.46	-0.89	19.71
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	78.86	60.11	2.5	-72.77	-18.66
Gross Profit, 3 Yr. CAGR %	75.02	46.95	2.5	-72.14	-18.66
EBITDA, 3 Yr. CAGR %	14.02	-3.07	-28.98	-36.34	3.99
EBITA, 3 Yr. CAGR %	14.03	-3.15	-29.01	-36.35	3.89
EBIT, 3 Yr. CAGR %	14.03	-3.15	-29.01	-36.35	3.89
Earnings From Cont. Operations, 3 Yr. CAGR %	57.26	-0.38	-29.08	-52.22	-3.44
Net Income, 3 Yr. CAGR %	57.26	-0.38	-37.52	-51.89	-18.41
Normalized Net Income, 3 Yr. CAGR %	15.62	0.01	-29.22	-37.99	-3.76
Diluted EPS Before Extra, 3 Yr. CAGR %	3.88	-50.1	-62.49	-73.21	-60.75
Accounts Receivable, 3 Yr. CAGR %	151.37	92.32	8.62	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	1.54	-45.89	-	-54.08	-16.51
Total Assets, 3 Yr. CAGR %	5.31	-13.54	-20.51	1.38	-0.07
Tangible Book Value, 3 Yr. CAGR %	-18.24	-19.2	21.09	33.26	2.31
Common Equity, 3 Yr. CAGR %	-18.24	-19.2	21.09	33.26	2.31
Cash From Operations, 3 Yr. CAGR %	37.12	-6.37	-26.45	-43.03	-15.53
Capital Expenditures, 3 Yr. CAGR %	-57.93	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	35.08	-7.51	-33.47	-47.97	2.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	33.46	-10.9	-33.15	-47.41	10.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	89.95	21.7	-33.5	-34.79	2.49
Gross Profit, 5 Yr. CAGR %	90.61	15.84	-33.46	-34.79	2.49
EBITDA, 5 Yr. CAGR %	41.91	18.15	-12.15	-17.11	-14.5
EBITA, 5 Yr. CAGR %	41.86	18.07	-12.17	-17.14	-14.57
EBIT, 5 Yr. CAGR %	41.86	18.07	-12.17	-17.14	-14.57
Earnings From Cont. Operations, 5 Yr. CAGR %	72.95	20.11	-12.38	-17.78	-16
Net Income, 5 Yr. CAGR %	72.95	20.11	-18.79	-17.44	-15.99
Normalized Net Income, 5 Yr. CAGR %	43.31	20.24	-12.23	-17.68	-16.09
Diluted EPS Before Extra, 5 Yr. CAGR %	27.49	-17.09	-39.04	-57.91	-65.87
Accounts Receivable, 5 Yr. CAGR %	119	18.57	-29.54	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	27.04	-17.71	-	-37.86	-46.22
Total Assets, 5 Yr. CAGR %	-2.29	-13.14	-12.67	-1.19	-3.79
Tangible Book Value, 5 Yr. CAGR %	-17.95	-17.85	-14.58	-0.76	24.27
Common Equity, 5 Yr. CAGR %	-17.95	-17.85	-14.58	-0.76	24.27
Cash From Operations, 5 Yr. CAGR %	61.45	15.54	-11.3	-18.07	-14.28
Capital Expenditures, 5 Yr. CAGR %	-25.73	-	-	-	-35.62
Levered Free Cash Flow, 5 Yr. CAGR %	57.63	14.24	-17.63	-21.76	-15.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	56.49	11.91	-17.63	-21.76	-15.6